Perosphere Technologies

Executive Summary

Perosphere Technologies is a private medical technology company developing innovative point-of-care coagulation diagnostics. Its flagship product, the Perosphere ClotChek, is a handheld, reagent-free coagulometer that provides a rapid, global view of a patient's coagulation status at the bedside. Unlike traditional coagulation tests that focus on specific clotting pathways, ClotChek offers a comprehensive assessment, enabling clinicians to make faster, more informed decisions in settings such as emergency departments, operating rooms, and intensive care units. The company's technology aims to address significant unmet needs in anticoagulation management, trauma care, and perioperative monitoring, where timely data can improve patient outcomes and reduce healthcare costs. With a strong intellectual property portfolio and a clear value proposition, Perosphere is positioned to disrupt the coagulation diagnostics market, which is currently dominated by central lab-based analyzers and limited point-of-care options. The company has yet to generate commercial revenue but has shown promising clinical results and is advancing toward regulatory submission.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for Perosphere ClotChek70% success
• Q1 2027First commercial launch and initial revenue generation60% success
• Q2 2027Strategic partnership or distribution agreement with a major healthcare company50% success